HERON THERAPEUTICS, INC. /DE/

HRTX Net selling

CIK 0000818033 #4644 in the set updated 21 Sep 2026

Bought (120 mo)

$50.30M

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$116.13M

$0.00 on a plan · $19.58M straight out of an exercise

Sold at will

$96.55M

16 of 34 sales

Net

−$65.83M

−$46.25M against sales at will

By person

22 insiders · 50 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

TANG KEVIN

Director

$40.00M (3)

$96.35M (1)

−$56.35M

5,821,098

3.07%

$8.73M

+4.3%

Rosen Robert

President

—

$8.77M (5) scheduled

−$8.77M

2,640

0.0014%

$3.96K

0.0%

Quart Barry D

Chief Executive Officer

$79.99K (1)

$7.40M (3) scheduled

−$7.32M

177,989

0.0938%

$266.98K

+195.1%

Morgan Adam

Director

$6.06M (2)

—

+$6.06M

8,877,027

4.68%

$13.32M

+97.3%

Rubric Capital Management LP entity

10% owner

$3.58M (1)

—

+$3.58M

30,046,828

15.83%

$45.07M

+12.5%

MANHARD KIMBERLY

EVP, Drug Development

—

$2.35M (13) scheduled

−$2.35M

28,330

0.0149%

$42.50K

—

Hoffman Robert E.

CFO & SVP, Finance

—

$1.15M (2) scheduled

−$1.15M

1,280

0.0007%

$1.92K

—

POYHONEN JOHN

President & CCO

$264.65K (3)

—

+$264.65K

46,648

0.0246%

$69.97K

—

Collard Craig A

Chief Executive Officer

$137.97K (1)

—

+$137.97K

856,492

0.4511%

$1.28M

+1,063%

Szekeres David Leslie

EVP, Chief Operating Officer

—

$85.18K (2)

−$85.18K

33,754

0.0178%

$50.63K

+845.2%

Duarte Ira

EVP, Chief Financial Officer

$75.60K (1)

—

+$75.60K

281,899

0.1485%

$422.85K

+675.0%

Forbes William P

EVP, Chief Development Officer

$74.25K (2)

—

+$74.25K

241,173

0.1270%

$361.76K

+5,929%

Johnson Craig A

Director

—

$13.61K (4)

−$13.61K

53,960

0.0284%

$80.94K

—

Christian Waage

Director

$25.26K (1)

$16.43K (4)

+$8.84K

53,960

0.0284%

$80.94K

—

Hensley Mark Earl

Chief Operating Officer

—

—

—

170,901

0.0900%

$256.35K

—

Rodriguez Susan

Director

—

—

—

87,180

0.0459%

$130.77K

+1,295%

Peraza Lisa

VP, Chief Accounting Officer

—

—

—

55,907

0.0294%

$83.86K

+396.6%

Kaseta Michael

Director

—

—

—

53,960

0.0284%

$80.94K

—

Cusack Thomas

Director

—

—

—

53,960

0.0284%

$80.94K

—

Dissanaike Sharmila

Director

—

—

—

53,960

0.0284%

$80.94K

—

DAVIS STEPHEN

Director

—

—

—

52,032

0.0274%

$78.05K

—

Drazba Brian G.

VP, Finance & CFO

—

—

—

3,798

0.0020%

$5.70K

+16.5%

Individual transactions

1

Insider

Date

Role

Action

Shares

Price

Amount

Quart Barry D

14 Sep 2018

Chief Executive Officer

Exercised, kept

19,675

$7.20

$141.66K

Show all 50 transactions →

What was left out

Form 4 filings counted 262

Amendments (4/A) skipped 6

Filings about a different issuer 0

Unreadable filings 0

Joint filings 5

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 18

Sales at will 16

Transactions with no price 0

Shares from compensation/vesting 4,052,063

Sales filed before the plan box existed 16

History held since 7 Oct 2016